Introduction

United Regional Health Care System (URHCS), a 300 licensed bed hospital located in Wichita Falls, Texas, provides comprehensive medical care, including inpatient and outpatient services, advanced diagnostics, surgical specialties, and life-saving emergency care to a nine-county service area.

Simplist^® is a platform of ready-to-administer prefilled syringes produced by Fresenius Kabi USA^®. Simplist manufacturer prepared prefilled syringes require no assembly at the bedside and are associated with a 4x lower error rate* compared to traditional practice.¹

Fresenius Kabi is committed to supporting opioid stewardship and recently launched Simplist Fentanyl Citrate Injection, USP 50 mcg per 1 mL in a prefilled syringe to help hospitals more closely match clinical practice to available product presentation. Optimizing product size ultimately helps to eliminate narcotic waste and supports reduced diversion opportunities.

URHCS was an early adopter of Simplist ready-to-administer medications and used seven different medications in the portfolio, realizing the benefits of a ready-to-administer syringe from a trusted manufacturer.

With the launch of Fentanyl 50 mcg per 1 mL in the Simplist line of ready-to-administer medications, the URHCS pharmacy team was interested in utilizing the product to reduce waste associated with nursing time as well as reduce potential for diversion. After deciding to move forward with the product, URHCS used Fresenius Kabi’s pharmacy support tool, called Optilytics^®, to implement the product, increasing space in their automated dispensing cabinets by 17%. The results were annually projected to eliminate 86 hours of Fentanyl wasting for nursing, eliminating 4,076 opportunities for diversion, reducing Fentanyl waste by 62%.

*A prospective, multisite, observational study of IV push medication preparation and administration compared the error rates between ready-to-administer products and traditional practice, including a cartridge-based syringe system and vial and syringe. Simplist was the only RTA delivery system used in the study. Study limitations include only a select number of sites (3) and steps observed.

The Challenge

Opioid stewardship is an ever-important subject for hospitals and health systems. There are significant costs associated with proper controlled substance disposal, management, and regulatory compliance.² Given the high abuse potential of fentanyl, hydromorphone, and morphine, it is imperative that product waste is minimized.²

While pain control is an integral part of providing treatment to patients, doing so creates operational challenges for hospitals. Specifically, narcotic waste requires significant nursing time spent documenting. For example, one study (Hertig²) estimated the amount of time each waste transaction requires is 76.2 seconds, not accounting for the waste witness (2nd RN) or pharmacy’s time to reconcile discrepancies. Additionally, each waste event opens the door for narcotic diversion. As such, United Regional felt that reducing waste was in the best interest of their operations, and ultimately, patient safety.

Lastly, when considering the addition of new syringe products, automated dispensing space can become a challenge. Often, cabinets are close to capacity, and the larger bins, which accommodate ready-to-administer (RTA) syringes, are completely utilized. To help minimize this obstacle to implementation, URHCS leveraged the pharmacy support services offered by Fresenius Kabi.

The Process

Waste Analysis

To understand the impact of narcotic waste, URHCS utilized internal reports to determine where medication waste was happening in the hospital and the volume in which it was occurring.

DATA OBSERVED

Fentanyl 100 mcg per 2 mL vials

Date Range: 181 days

Total Waste Events: 3,812

Using Fresenius Kabi’s Waste Calculator based on the framework demonstrated in A Continuous Observation Workflow Time Study to Assess Intravenous Push Waste², URHCS calculated that Fentanyl 100 mcg per 2 mL vial waste was demanding 162 hours of nursing time per year. That figure excludes accounting for waste witness and pharmacy operations time. The total waste amount was equivalent to 5,004 vials of Fentanyl 100 mcg per 2 mL per year. Using the average wholesale price for Fentanyl combined with workforce time wasted, the dollars wasted per year totaled $32,223.61. This analysis supported that reducing the number of Fentanyl waste events would benefit URHCS from an operational cost perspective.

Storage Optimization

At URHCS, Fentanyl 100 mcg per 2 mL vials were found to be stored in 41 automated dispensing cabinets. The pharmacy team hoped to implement the Simplist Fentanyl 50 mcg per 1 mL prefilled syringes by matching par levels of the Fentanyl 100 mcg per 2 mL vials. While implementing the new syringes, the URHCS team reduced their current Fentanyl 100 mcg per 2 mL vial inventory by 50%. The pharmacy support team at Fresenius Kabi has a unique offering to support customers. They use a proprietary analytics tool called Optilytics^®, which is complimentary for Simplist customers.

Optilytics is a tool that analyzes each cabinet to create space for customers to implement Simplist^®. The storage team utilized a couple of standard reports from URHCS’s ADS and generated a plan to fit the new product. The pharmacy support team came onsite to help the pharmacy team implement the product.